Clinical Trials
64 trialsAAPICO
Centre Hospitalier Departemental Vendee
Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
National Taipei University of Nursing and Health Sciences
LaserSAFE
University College, London
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
Shanghai Zhongshan Hospital
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
National Institutes of Health Clinical Center (CC)
DINGO
St Vincent's Hospital, Sydney
MIDAS-Prostate
University Health Network, Toronto
ACCESS-PC
Rutgers, The State University of New Jersey
Endeavor-2
University Hospital, Antwerp
Rezvilutamide for High-Risk Prostate Cancer After Surgery
Fujian Medical University Union Hospital
Robot-Assisted Radical Prostatectomy: the HOOD Technique Versus Standard Anterior Reconstruction
Ankara University
PSMA PET for Surveillance After Focal Therapy
University of Chicago
DESTINATION 2
The Netherlands Cancer Institute
SPAR
Clinique Sainte Clotilde
MicroUSgFLA
University Health Network, Toronto
NICE-PSMA
Martini-Klinik am UKE GmbH
FIRSTLUNG
Delfi Diagnostics Inc.
Treatment of Multifocal Lung Adenocarcinoma
Mayo Clinic
KP-CARAIBES
Centre Hospitalier Universitaire de la Guadeloupe
DE-CART
Fox Chase Cancer Center
NeoResII
Karolinska University Hospital
Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer
Hunan Cancer Hospital
JUMP
Brigham and Women's Hospital
IP7-PACIFIC
Imperial College London
PROSTIA- BP
Central Hospital, Nancy, France
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Chinese University of Hong Kong
Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial
East and North Hertfordshire NHS Trust
Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
URO-ROBOT-2023
IRCCS Azienda Ospedaliero-Universitaria di Bologna
ARISTA
St. Antonius Hospital Gronau
Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
University Hospital Ostrava
HEPATOXALI
University Hospital, Clermont-Ferrand
Beyond TME Origins
Imperial College London
Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients
Universitaire Ziekenhuizen KU Leuven
BLADE
University Hospital, Montpellier
LACC
Queensland Centre for Gynaecological Cancer
DIPLOMA
University Hospital, Montpellier
Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer
University of Rochester
PANTELO
Institut Cancerologie de l'Ouest
Node
UMC Utrecht
Focal Prostate Radio-Frequency Ablation
H. Lee Moffitt Cancer Center and Research Institute
Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer
Rigshospitalet, Denmark
MuSE
University of Cambridge
Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial.
University of California, Irvine
PROSPECT
Hospices Civils de Lyon
Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer
Odense University Hospital
PET LACE
Ontario Clinical Oncology Group (OCOG)
PAPAFA
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Surgical Management of Multiple Mucoepidermoid Carcinoma and Adenocarcinoma
Ain Shams University
HIPPO-S
Universitätsmedizin Mannheim